Pacira BioSciences PCRX
NASDAQ PCRX
$36.46 -0.03 (-0.08%)
At close: Nov 11, 2026 · 4:00 PM EST

Pacira BioSciences (PCRX) Other Accumulated Expenses (2010 - 2019)

Updated

Pacira BioSciences' Other Accumulated Expenses was $360,000 in Q4 2012, up 4.3% from $345,000 a year earlier.

Analysis

Pacira BioSciences (PCRX) Other Accumulated Expenses (2010 - 2019) Analysis & Trends

  • In earlier years, Other Accumulated Expenses was $345,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pacira BioSciences 1.46 Bn 468.61 Mn 139.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 18.18 Mn
Dec 31, 2012 360,000.00
Dec 31, 2011 345,000.00
Dec 31, 2010 500,000.00
API Access

Pacira BioSciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PCRX&period=max&api_key=YOUR_API_KEY